Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers' work adds to breast cancer body of knowledge
July 7th, 2005
Breast cancer data are the focus of recent research from the United States and Italy. Study 1: Baseline spinal bone mineral density may predict risk of chemotherapy-induced ovarian failure in breast cancer patients, Ohio State University researchers say. "Age at treatment and the total cumulative dose of cyclophosphamide are established predictors of chemotherapy-induced ovarian failure in premenopausal women with breast cancer. In a prospective trial of 49 women receiving adjuvant chemotherapy, we sought to identify whether other factors including family history of osteoporosis, lifestyle factors, reproductive hormones, bone turnover markers, or...
Source: Women's Health Weekly (2005-07-07)
|
